Search for: "BAYER MANUFACTURING" Results 681 - 700 of 982
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Oct 2010, 8:19 pm by Christina D. Frangiosa
Bayer has successfully protected "ASPIRIN" worldwide (e.g., Canada, Reg. [read post]
11 Oct 2010, 3:09 pm
Drug makers, pharmacists and doctors all have a duty to make sure that the drugs they manufacture and prescribe to patients do not cause injury or harm. [read post]
27 Sep 2010, 6:37 am by Beth Graham
”  Based upon various representations made by both Bridon and Certex regarding the strength of Bridon’s ropes, Noble entered into a sales contract with Certex to purchase wire rope manufactured by Bridon. [read post]
27 Sep 2010, 4:55 am by Brenda Fulmer
Beyaz is a drug that never should have been manufactured by Bayer or approved by the FDA. [read post]
12 Sep 2010, 4:04 am by Asbestos Litigation
"With the signing of the agreement has achieved a leading European manufacturer of sealing material distributes a wide variety of its products in Germany," said Frank Funke, director of sales of the company Dr. [read post]
10 Sep 2010, 1:05 am
The active members of the circuit issued a brief ruling Tuesday saying they had voted to deny rehearing en banc a case in which a three-judge panel in April affirmed summary judgment for Bayer AG on a Sherman Act challenge concerning a so-called "pay-for-delay" agreement involving the antibiotic drug Cipro. [read post]
8 Sep 2010, 3:21 pm
The plaintiffs challenged the patent settlement agreement between the owner of the patent for the active ingredient in Cipro and potential generic manufacturers of Cipro as an illegal market-sharing agreement. [read post]
8 Sep 2010, 11:29 am by Hopkins
Bayer manufactured Trasylol and originally set forth its indication for use as: "For prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass (CPB) in the course of coronary artery bypass graft (CABG) surgery" The FDA approved Trasylol in 1993, for use in cardiopulmonary bypass grafting surgery to reduce perioperative blood loss and eliminate the need for blood transfusion. [read post]
8 Sep 2010, 11:29 am by Hopkins
Bayer manufactured Trasylol and originally set forth its indication for use as: "For prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass (CPB) in the course of coronary artery bypass graft (CABG) surgery" The FDA approved Trasylol in 1993, for use in cardiopulmonary bypass grafting surgery to reduce perioperative blood loss and eliminate the need for blood transfusion. [read post]
8 Sep 2010, 4:30 am
In five separate, mostly identical complaints in state court, the plaintiffs sued Bayer for personal injuries they alleged were caused by Trasylol, a prescription medication manufactured by Bayer. [read post]
7 Sep 2010, 11:47 am by Antitrust Today
  The plaintiffs sued Bayer and generic manufacturers of the blockbuster antibiotic Cipro, alleging that Bayer’s payment of hundreds of millions of dollars to the generics in settlement of patent infringement litigation violated the antitrust laws. [read post]
2 Sep 2010, 5:00 am
However, it is the responsibility of the manufacturer to do everything in their power to produce a drug that is as safe as possible for consumer use. [read post]
2 Sep 2010, 5:00 am by Anapol Schwartz
However, it is the responsibility of the manufacturer to do everything in their power to produce a drug that is as safe as possible for consumer use. [read post]
1 Sep 2010, 4:14 am by Lawrence B. Ebert
"It was manufactured in China using an old mold that still had the expired patent number on it," says Mr. [read post]
27 Aug 2010, 2:41 pm by Bexis
 “[U]nless the manufacturer’s breach of its duty to test leads the manufacturer t [read post]
10 Aug 2010, 8:44 pm by Marie Louise
  Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
8 Aug 2010, 10:11 am by Dr. Shezad Malik
The New Jersey Yaz litigation was consolidated because of concerns about court filings, since New Jersey is the corporate headquarters in the United States for Bayer Healthcare Pharmaceuticals, Inc., which manufacturers the birth control pills. [read post]